Timothy Rost, MD
Obstetrics & Gynecology · Grapevine, TXNPI 1275539439
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $9,600 of the $10,602 with a category attached, or 90.5%. Mimedx Group, Inc. accounts for 90.5% of it on its own, with 24 other manufacturers making up the rest. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 74 payments — averaging $143.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$10K
- AbbVie$199
- Exeltis, USA Inc.$95
- Therapeuticsmd, Inc.$61
- Astellas Pharma US Inc$58
- Merck$58
- plus $532 from 19 others
What the payments were for
- Consulting fees$9,60091%
- Food & beverage$9649%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 18 | $9,600 |
| AbbVie(2 entities) | 11 | $199 |
| Exeltis, USA Inc. | 6 | $95 |
| Therapeuticsmd, Inc. | 4 | $61 |
| Astellas Pharma US Inc | 3 | $58 |
| Merck | 3 | $58 |
| Agile Therapeutics, Inc. | 3 | $56 |
| Myovant Sciences Inc. | 2 | $47 |
| Avion Pharmaceuticals | 3 | $46 |
| Duchesnay USA Incorporated | 2 | $42 |
| AMAG Pharmaceuticals, Inc. | 3 | $38 |
| Pacira Pharmaceuticals Incorporated | 2 | $38 |
| Johnson & Johnson | 1 | $37 |
| Hologic Sales And Service, LLC | 2 | $28 |
| Biogen | 1 | $23 |
| Mallinckrodt Hospital Products Inc. | 1 | $22 |
| Pfizer | 1 | $21 |
| Organon | 1 | $21 |
| Millicent US Inc | 1 | $20 |
| BD | 1 | $20 |
| Evofem Biosciences, Inc. | 1 | $18 |
| Aspira Women's Health Inc | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $14 |
| Mylan Pharmaceuticals Inc. | 1 | $14 |
| Channel Medsystems, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOVINE COLLAGEN$2,000
How this compares
$10,602 in reported general payments places this provider in the 90th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 25 | $474 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Grapevine
- Scott LauerGrapevine$52K
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.